|
Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
This book provides a comprehensive overview of the biology of the
endoplasmic reticulum (ER) and the associated ER proteins, it
discusses their structure, function and signaling mechanisms in the
cell and their role in disease. This book also offers insights into
the practical aspects of research and demonstrates the use of
non-mammalian models to study the structure and function of the ER.
Written by leading experts in the field, the book enables readers
to gain a thorough understanding of current ER biology. It is
intended for scientists and clinical researchers working on the
endoplasmic reticulum in all its various roles and facets in health
and disease.
Various "omics" methods have recently revolutionized molecular
diagnostics. Next-generation sequencing (NGS) makes it possible to
sequence a human genome in just one day. Whole genome sequencing
(WGS) greatly improves the ability to investigate the outbreaks of
numerous pathogens. Metagenomics helps to analyze the microbiome,
which aids greatly in identifying the pathogenesis of infectious
diseases. Proteomic-based methods, namely matrix-assisted laser
desorption-ionization time of flight mass spectrometry
(MALDI-TOF-MS), have a promising role in identifying myctobacteria
and fungi, and predicting antimicrobial resistance. While there are
numerous scientific publications on "omics" applications for
microbiology, there are relatively few books that review this topic
from a clinical diagnostics perspective. This book looks at this
field from a holistic viewpoint, instead of limiting by type of
"omics" technology, in order to cover the body of knowledge needed
for practitioners and academics interested in clinical and public
health microbiology. Additionally, it addresses the management,
economical, regulatory and operational aspects of integrating these
technologies into routine diagnostics.
Leading researchers are specially invited to provide a complete
understanding of a key topic within the multidisciplinary fields of
physiology, biochemistry and pharmacology. In a form immediately
useful to scientists, this periodical aims to filter, highlight and
review the latest developments in these rapidly advancing fields.
Respiratory diseases are leading causes of death and disability
globally, with about 65 million people suffering from COPD, and 334
million from asthma, the most common chronic disease. Each year,
tens of millions of people develop and can die from from
respiratory infections such as pneumonia and TB. Systemic
inflammation may induce and exacerbate local inflammatory diseases
in the lungs, and local inflammation can in turn cause systemic
inflammation. There is increasing evidence of the coexistence of
systemic and local inflammation in patients suffering from asthma,
COPD, and other lung diseases, and the co-morbidity of two or more
local inflammatory diseases often occurs. For example, rheumatoid
arthritis frequently occurs together with, and promotes the
development of, pulmonary hypertension. This co-morbidity
significantly impacts quality of life, and can result in death for
those affected. Current treatment options for lung disease are
neither effective, nor condition-specific; there is a desperate
need for novel therapeutics in the field. Additionally, the
molecular and physiological significance of most major lung
diseases is not well understood, which further impedes development
of new treatments, especially in the case of coexistent lung
diseases with other inflammatory diseases. Great progress has been
made in recent years in many areas of the field, particularly in
understanding the molecular geneses, regulatory mechanisms,
signalling pathways, and cellular processes within lung disease, as
well as basic and clinical technology, drug discovery, diagnoses,
treatment options, and predictive prognoses. This is the first text
to aggregate these developments. In two comprehensive volumes,
experts from all over the world present state-of-the-art advances
in the study of lung inflammation in health and disease.
Contributing authors cover well-known as well as emerging topics in
basic, translational, and clinical research, with the aim of
providing researchers, clinicians, professionals, and students with
new perspectives and concepts. The editors hope these books will
also help to direct future research in lung disease and other
inflammatory diseases, and result in the development of novel
therapeutics.
This edited volume discusses the application of very diverse human
organotypic models in major areas of biomedical research. The
authors lay a main focus on infectious diseases, cancer, allergies,
as well as drug/vaccine discovery and toxicology studies.
Representing a valid alternative to laboratory animals, these
models are relevant for most areas of translational research. As
the contemporary research shows, many human tissues can today be
cultivated in vitro and used for several research objectives. This
book provides an unprecedented overview of recent developments in
an exciting field of research methodology. It is a reference guide
for scientists in both academia and industry. Readers can update
their knowledge and get hands-on recommendations on how to set up
an organotypic model in their lab. Chapters 'Progress on
Reconstructed Human Skin Models for Allergy Research and
Identifying Contact Sensitizers' and 'Human Organotypic Models for
Anti-infective Research' of this book are available open access
under a CC BY 4.0 license at link.springer.com.
This research volume examines the available alternative,
complementary, pharmaceutical and vaccine methods for treating,
mitigating, or preventing COVID-19. Coverage includes traditional
Chinese medicine, herbal remedies, nutraceutical/dietary options,
and drug/vaccine therapies. All the methods discussed will be
critically examined to provide readers with a full, unbiased
overview that includes pros/cons of each method. While the nature
of COVID-19 is still being studied, and new research and theories
are being published daily, this book endeavors to provide readers
with a comprehensive summary of current research on alternative and
mainstream treatment and prevention methods.
This up-to-date immunology textbook provides a clear and simple
introduction to clinical and laboratory immunology for health
professionals in training or in practice. It covers:
- essential basic immunology
- clinical immunology
- laboratory investigations of immunological disorders
- treatments used in immunological disorders.
Focusing on clinical problems seen in practice and including
self-assessment questions and case histories to aid learning and
understanding, this is an invaluable resource for all medical
students, nurses, nutritionists, pharmacists and
physiotherapists.
This up-to-date immunology textbook provides a clear and simple
introduction to clinical and laboratory immunology for health
professionals in training or in practice. It covers:
- essential basic immunology
- clinical immunology
- laboratory investigations of immunological disorders
- treatments used in immunological disorders.
Focusing on clinical problems seen in practice and including
self-assessment questions and case histories to aid learning and
understanding, this is an invaluable resource for all medical
students, nurses, nutritionists, pharmacists and
physiotherapists.
Microbial Diversity in the Genomic Era presents insights on the
techniques used for microbial taxonomy and phylogeny, along with
their applications and respective pros and cons. Though many
advanced techniques for the identification of any unknown bacterium
are available in the genomics era, a far fewer number of the total
microbial species have been discovered and identified to date. The
assessment of microbial taxonomy and biosystematics techniques
discovered and practiced in the current genomics era with suitable
recommendations is the prime focus of this book.
This edited volume explores Campylobacter species, which are some
of the most important foodborne pathogens. Above all, contaminated
poultry meat can cause human gastroenteritis in both developed and
developing countries. The respective contributions reveal how these
infections can also increase the risk of generalized paralytic
diseases such as Guillain-Barre syndrome, Miller-Fisher syndrome,
and Chinese paralytic syndrome. Due to their influence on the
nervous system, circulatory system, and various organs,
Campylobacter infections represent a serious public health concern.
Campylobacter can be effectively combated by addressing the
hygienic conditions in both food production and human lifestyles.
Accordingly, the authors put forward a One Health perspective,
which provides readers with essential insights into the basic
biology of Campylobacter, as well as practical guidance on aspects
ranging from food production to the clinical treatment of
infections. Chapters 'Population Biology and Comparative Genomics
of Campylobacter Species' and 'Natural Competence and Horizontal
Gene Transfer in Campylobacter' are available open access under a
Creative Commons Attribution 4.0 International License via
link.springer.com.
With detailed contributions from more than 40 leading authorities,
this edition comprehensively explores the immunobiology,
pathophysiology, and clinicial manifestations of graft-versus-host
disease (GvHD), offering sections revealing the most up-to-date
research on immune activation and dysregulation, the
pathophysiology of target organ damage, and GvHD prevention and
treatment. 53 illustrations.
|
|